These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31837576)

  • 81. Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy.
    Perri F; Ionna F; Longo F; Della Vittoria Scarpati G; De Angelis C; Ottaiano A; Botti G; Caponigro F
    Transl Oncol; 2020 Feb; 13(2):262-274. PubMed ID: 31869751
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Neoadjuvant immunotherapy in resectable head and neck cancer: oral cavity carcinoma as a potential research model.
    Gutiérrez Calderón V; Cantero González A; Gálvez Carvajal L; Aguilar Lizarralde Y; Rueda Domínguez A
    Ther Adv Med Oncol; 2021; 13():1758835920984061. PubMed ID: 33747147
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immunotherapy for Esophageal Cancer: State-of-the Art in 2021.
    Teixeira Farinha H; Digklia A; Schizas D; Demartines N; Schäfer M; Mantziari S
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158822
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Metastatic tumors to the oral cavity: a clinical study of 18 cases.
    Jham BC; Salama AR; McClure SA; Ord RA
    Head Neck Pathol; 2011 Dec; 5(4):355-8. PubMed ID: 21805337
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition.
    Capalbo C; Belardinilli F; Filetti M; Parisi C; Petroni M; Colicchia V; Tessitore A; Santoni M; Coppa A; Giannini G; Marchetti P
    Mol Clin Oncol; 2018 Jul; 9(1):30-34. PubMed ID: 29977536
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma.
    Gougis P; Moreau Bachelard C; Kamal M; Gan HK; Borcoman E; Torossian N; Bièche I; Le Tourneau C
    JNCI Cancer Spectr; 2019 Dec; 3(4):pkz055. PubMed ID: 32337482
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Emerging and Experimental Agents for Anal Cancer: What is New?
    Farias JPF; Rangel da Silva MHC; Jácome AA
    J Exp Pharmacol; 2021; 13():433-440. PubMed ID: 33859504
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Follow-Up of Head and Neck Cancer Survivors: Tipping the Balance of Intensity.
    Szturz P; Van Laer C; Simon C; Van Gestel D; Bourhis J; Vermorken JB
    Front Oncol; 2020; 10():688. PubMed ID: 32435619
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Long-term efficacy of immune checkpoint inhibitors with or without chemotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a commentary on the 4-year follow-up of the KEYNOTE-048 trial.
    Sano D; Oridate N
    Transl Cancer Res; 2023 May; 12(5):1363-1367. PubMed ID: 37304541
    [No Abstract]   [Full Text] [Related]  

  • 90. Current management approach to hidradenocarcinoma: a comprehensive review of the literature.
    Soni A; Bansal N; Kaushal V; Chauhan AK
    Ecancermedicalscience; 2015; 9():517. PubMed ID: 25815059
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Novel therapies in the management of oral cancer: An update.
    Nandini DB; Rao RS; Hosmani J; Khan S; Patil S; Awan KH
    Dis Mon; 2020 Dec; 66(12):101036. PubMed ID: 32594997
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group.
    González-Del-Alba A; Conde-Moreno AJ; García Vicente AM; González-Peramato P; Linares-Espinós E; Climent MÁ; The Sogug Multidisciplinary Working Group
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267437
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Radiotherapy, Chemotherapy and Immunotherapy-Current Practice and Future Perspectives for Recurrent/Metastatic Oral Cavity Squamous Cell Carcinoma.
    Melo-Alvim C; Neves ME; Santos JL; Abrunhosa-Branquinho AN; Barroso T; Costa L; Ribeiro L
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611391
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Cure in metastatic breast cancer.
    Westphal T; Gampenrieder SP; Rinnerthaler G; Greil R
    Memo; 2018; 11(3):172-179. PubMed ID: 30220923
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Is Chemotherapy with Carboplatin and 5-Fluorouracil Effective, Worthwhile Palliative Treatment in Recurrent/Metastatic Non-oral Cavity Head and Neck Carcinoma?
    Iqbal MS; Gray I; Jackson M; Kovarik J; Kelly C
    Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):546. PubMed ID: 32321659
    [No Abstract]   [Full Text] [Related]  

  • 96. Chemotherapy and/or immune checkpoint inhibitors in NSCLC first-line setting: what is the best approach?
    Gravara LD; Battiloro C; Cantile R; Letizia A; Vitiello F; Montesarchio V; Rocco D
    Lung Cancer Manag; 2020 Feb; 9(1):LMT22. PubMed ID: 32256708
    [No Abstract]   [Full Text] [Related]  

  • 97. Is the "P-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?
    Kus T; Aktas G; Cicin I
    Oncologist; 2024 Mar; 29(3):190-191. PubMed ID: 37294662
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Comprehensive oral cancer care protocols during COVID-19 in an institutional setting.
    Varma SR; Jaber M; Amjed Alsaegh M
    Oral Dis; 2022 Apr; 28 Suppl 1():986-987. PubMed ID: 32881187
    [No Abstract]   [Full Text] [Related]  

  • 99. Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189.
    Sheela S; Kim ES; Mileham KF
    J Thorac Dis; 2018 Sep; 10(9):5186-5189. PubMed ID: 30416764
    [No Abstract]   [Full Text] [Related]  

  • 100. Translating KEYNOTE-048 into practice recommendations for head and neck cancer.
    Szturz P; Vermorken JB
    Ann Transl Med; 2020 Aug; 8(15):975. PubMed ID: 32953775
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.